Alpha Cognition Inc. Common Stock

Alpha Cognition's FY2025 was defined by significant operating losses and cash burn as early commercialization of ZUNVEYL drove costs far beyond nascent revenue, creating continued reliance on external financing to fund operations and future development.

Revenue breakdown: Product Net (62.8%), License (31.7%), Licensing (5.5%).